Cannabidiol is a non-psychoactive cannabis compound touted for its medicinal promise–but marijuana- and hemp-derived extracts rich in CBD and low in intoxicating THC are facing a future yet to be determined.
The Cannabist’s special report “CBD, TBD” explores a regulatory and legal landscape pockmarked by federal-state conflicts, national drug policy, pioneering research efforts and disparate avenues toward the compound’s full legalization.
Seizures are a constant in Nancy Pasiecznik’s life.
In a typical month, they come by the dozen. In some months, they have come on the…